…Europe. Meaning there is still a lot of space to grow. “Today we can get the entire human genome sequence in 24 hours for $500. This has opened up the…
…after fighting it off; the bacteria then integrate that DNA into its own genome as a spacer using a nuclease, most commonly Cas9. This is a highly specific tunable mechanism,…
…of edits and insertions into the genome to deliver therapeutic genes. Tessera’s Gene Writing technology is based on a different concept to CRISPR called mobile genetic elements (MGEs). These are…
…growing evidence in Genomic Studies shows that there are key genetic players in the Aging game… Ever since the Human Genome Project, which began 25 years ago, the tools available…
…with six genome copies, is the result of hybridizations between three species that had two genome copies each, which happened over 10,000 years ago. By multiplying the DNA load, Kaiima…
…Cas nucleases, G-dase E is the first to demonstrate a substantial cytotoxic effect in targeted cells, caused by the degradation of the genome. Contrary to Cas9-based editing events, G-dase E…
…Babraham Institute in Cambridge, UK, with colleagues from Brazil and Italy, have discovered a mechanism by which helpful bacteria in the gut can control the genes in our genome. The…
…report here. Here are the 10 women in Biotech who really caught my attention… The Wellcome Genome Campus in Hinxton, Cambridge (Source: Wellcome Genome Campus) Fiona Marshall – Heptares Therapeutics…
…technology to target and remove latent viral DNA embedded within the host genome. Its lead candidate, EBT-101, employs an adeno-associated virus (AAV) delivery system to introduce CRISPR-Cas9 along with dual…
…said Bob Zhang, co-founder and CEO of Epigenic Therapeutics. “Along with our scientific co-founders and advisers, we are able to expand our understanding of precise regulation of epigenetic genome, and…
…modification of the human genome, which brings the promise of using CRISPR to cure diseases. Since 2012, a lot has happened and drug candidates have progressed so far that one…
…therapeutically-relevant genome-editing technologies targeting the specific needs of patients. The company’s tools for in vivo genome editing directly modify genes within the body, offering several key benefits in safety, efficacy…